Advertisement
Canada markets closed
  • S&P/TSX

    22,373.38
    +52.51 (+0.24%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.29 (+0.01%)
     
  • CAD/USD

    0.7341
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    78.61
    +0.89 (+1.15%)
     
  • Bitcoin CAD

    94,501.62
    +1,198.62 (+1.28%)
     
  • CMC Crypto 200

    1,495.34
    +11.15 (+0.75%)
     
  • GOLD FUTURES

    2,353.20
    +18.70 (+0.80%)
     
  • RUSSELL 2000

    2,069.67
    +21.26 (+1.04%)
     
  • 10-Yr Bond

    4.4670
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,911.00
    +35.00 (+0.19%)
     
  • VOLATILITY

    12.36
    +0.43 (+3.60%)
     
  • FTSE

    8,317.59
    -21.64 (-0.26%)
     
  • NIKKEI 225

    38,900.02
    0.00 (0.00%)
     
  • CAD/EUR

    0.6753
    +0.0001 (+0.01%)
     

Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.

Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.

Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.